Arthur L. Burnett II, MD, MBA, FACS, Author at Grand Rounds in Urology

Arthur L. Burnett II, MD, MBA, FACS

Johns Hopkins University School of Medicine

Baltimore, Maryland

Arthur L. Burnett II, MD, MBA, FACS, is a Professor in the Department of Urology and Director of the Basic Science Laboratory in Neuro-Urology at Johns Hopkins University School of Medicine. His professional appointments at the Johns Hopkins Hospital include Director of the Male Consultation Clinic and Clinician-Scientist at the James Buchanan Brady Urological Institute. Dr. Burnett earned his undergraduate degree in biology from Princeton University and his medical degree at Johns Hopkins University School of Medicine. He completed his internship and residency in surgery and, subsequently, residency and fellowship in urology at the Johns Hopkins Hospital. After completing his urology residency, Dr. Burnett received an American Foundation of Urologic Disease New Investigator Award to continue research into the regulatory mechanisms of penile erection. Since then, he has maintained an active laboratory in neuro-urology.

Dr. Burnett is recognized as a world-authority in the science and medicine of male erectile dysfunction. He has contributed original discoveries about the nitric oxide biochemical mechanisms in erectile tissue that have paved the way for the clinical development of oral medications to treat erectile dysfunction. He has also done pioneering work developing therapies to protect the penile nerve function required for improved erectile function recovery after radical prostatectomy.

Dr. Burnett has written more than 150 original peer-reviewed articles, along with numerous additional articles, editorials, and book chapters, relating to his biomedical research and clinical activities. His work has appeared in many major journals including Science, Nature Medicine, Proceedings of the National Academy of Sciences, Journal of Urology, Urology, and Journal of Andrology. He is a Fellow of the American College of Surgeons, as well as a member of the American Urological Association, the Sexual Medicine Society of North America, the International Society for Sexual Medicine, the Society of Genitourinary Reconstructive Surgeons, the Society for Urodynamics and Female Urology, and the Society of Black Academic Surgeons. He has sat on various advisory committees, including the Urology Study Section, the National Institutes of Health Center for Scientific Review, and the FDA Advisory Committee for Reproductive Health Drugs.

Disclosures:

Talks by Arthur L. Burnett II, MD, MBA, FACS

New Concepts in Cavernous Nerve Localization and Functional Recovery after Radical Prostatectomy

Posted by Arthur L. Burnett II, MD, MBA, FACS | May 2020

Arthur L. Burnett II, MD, MBA, FACS, Professor of Urology at Johns Hopkins University School of Medicine, discusses therapeutic and investigational strategies for improving erectile function after prostatectomy. He goes on to discuss how cavernous nerve-sparing techniques have reduced erectile dysfunction after prostatectomy by 10-40%, how mapping cavernous nerves with novel imaging techniques can help minimize nerve and vascular injury at the time of surgery, as well as the impact of investigational, local electrostimulation of damaged cavernous nerves in an animal model cohort.

Ethnic Disparities in Sexual Dysfunction Outcomes After Prostate Cancer Treatment: Myth or Reality?

Posted by Arthur L. Burnett II, MD, MBA, FACS | Mar 2020

Arthur L. Burnett II, MD, MBA, FACS, Professor of Urology and Director of the Basic Science Laboratory in Neuro-Urology at Johns Hopkins University School of Medicine, discusses potential disparities that exist among different ethnic minorities that may impact treatment-related sexual dysfunction following treatment for prostate cancer. He goes on to discuss racial and ethnic disparities in the prostate cancer treatment landscape, review of prior studies that discuss the possible psychosocial and cultural determinants that impact these outcomes, as well as propose possible approaches to address the problem of sexual dysfunction after prostate cancer treatment amongst various ethnic minority groups.

Penile Allotransplantation: An Advance in Genitourinary Reconstruction

Posted by Arthur L. Burnett II, MD, MBA, FACS | Sep 2019

Arthur L. Burnett II, MD, MBA, presents penile allotransplantation as an emerging alternative to autogenous reconstruction. He discusses the benefits for military trauma patients in particular, and the importance of considering potential complications as well as improved quality of life.

New Frontiers in Cavernous Nerve Restorative Therapy to Preserve Erectile Function after Radical Prostatectomy

Posted by Arthur L. Burnett II, MD, MBA, FACS | Aug 2019

Arthur L. Burnett II, MD, MBA, FACS, presents the rationale for invoking therapeutic strategies for enhancing erectile function recovery following radical prostatectomy. He assesses possible therapeutic strategies that target the cavernous nerve in order to restoring erectile function and identifies the requirements and future possibilities for penile rehabilitation success.